| 1 |
Antihyperglycaemic activity of ethylacetate extract of Chlorophytum alismifolium in type 2 diabetes: The involvement of peroxisome proliferator-activated receptor-? and dipeptidyl peptidase-4 |
|
|
| Abdulhakim Abubakar,Abdullahi Balarabe Nazifi,Idris Mohammed Maje,Yusuf Tanko,Joseph Akpojo Anuka,Ezzeldin Mukthar Abdurahman |
|
| Journal of Integrative Medicine. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Effects of Spirulina platensis on insulin secretion, dipeptidyl peptidase IV activity and both carbohydrate digestion and absorption indicate potential as an adjunctive therapy for diabetes |
|
|
| J. M. A. Hannan,Prawej Ansari,Shofiul Azam,Peter R. Flatt,Yasser H. A. Abdel Wahab |
|
| British Journal of Nutrition. 2020; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Targeting type II diabetes with plant terpenes: the new and promising antidiabetic therapeutics |
|
|
| Suchitra K. Panigrahy,Renu Bhatt,Awanish Kumar |
|
| Biologia. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Anti-hyperglycaemic activity of H. rosa-sinensis leaves is partly mediated by inhibition of carbohydrate digestion and absorption, and enhancement of insulin secretion |
|
|
| Prawej Ansari,Shofiul Azam,J.M.A. Hannan,Peter R. Flatt,Yasser H.A. Abdel Wahab |
|
| Journal of Ethnopharmacology. 2020; : 112647 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Invitro modulation of glucagon-like peptide release by DPP-IV inhibitory polyphenol-polysaccharide conjugates of sprouted quinoa yoghurt |
|
|
| Obaroakpo Joy Ujiroghene,Lu Liu,Shuwen Zhang,Jing Lu,Liu Liu,Xiaoyang Pang,Jiaping Lv |
|
| Food Chemistry. 2020; : 126857 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind trial |
|
|
| Jordan Kraaijenhof,Marcel H. A. Muskiet,Lennart Tonneijck,D. Margriet Ouwens,Mark H. H. Kramer,Daniël H. Raalte,Mark M. Smits |
|
| Diabetes, Obesity and Metabolism. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Development of diarylpentadienone analogues as alpha-glucosidase inhibitor: Synthesis, in vitro biological and in vivo toxicity evaluations, and molecular docking analysis |
|
|
| Maryam Aisyah Abdullah,Yu-Ri Lee,Siti Nurulhuda Mastuki,Sze Wei Leong,Wan Norhamidah Wan Ibrahim,Muhammad Alif Mohammad Latif,Aizi Nor Mazila Ramli,Mohd Fadhlizil Fasihi Mohd Aluwi,Siti Munirah Mohd Faudzi,Cheol-Hee Kim |
|
| Bioorganic Chemistry. 2020; 104: 104277 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Discovery of Highly Polar ß-homophenylalanine Derivatives as Non-systemic Intestine-Targeted Dipeptidyl Peptidase IV Inhibitors |
|
|
| Fubao Huang,Mengmeng Ning,Kai Wang,Jia Liu,Wen bo Guan,Ying Leng,Jianhua Shen |
|
| Journal of Medicinal Chemistry. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Protective role of sitagliptin against oxidative stress in a kainic acid-induced status epilepticus in rats models via Nrf2/HO-1 pathway |
|
|
| Chong-Hao Wang,Na Zhu |
|
| Drug Development Research. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
The Role of Glucagon-Like Peptide-1 in Energy Homeostasis |
|
|
| Marzieh Salehi,Jonathan Q. Purnell |
|
| Metabolic Syndrome and Related Disorders. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Dynamics of switching, adherence, and persistence of dipeptidyl peptidase-4 inhibitors use: a nationwide cohort study |
|
|
| Richard Ofori-Asenso,Jenni Ilomaki,Ken Lee Chin,Mohsen Mazidi,Ella Zomer,J. Simon Bell,Dianna J. Magliano,Danny Liew |
|
| Diabetes Research and Clinical Practice. 2019; : 107909 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
A comprehensive review of bioactive peptides obtained from animal byproducts and their applications |
|
|
| Julia Bechaux,Philippe Gatellier,Jean-François Le Page,Yoan Drillet,Véronique Sante-Lhoutellier |
|
| Food & Function. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Therapeutic experience of saxagliptin as first add-on after metformin in Indian type 2 diabetes patients: A non-interventional, prospective, observational study (ONTARGET-INDIA) |
|
|
| Sanjay Kalra,Sarita Bajaj,AG Unnikrishnan,ManashP Baruah,Rakesh Sahay,V Hardik,Amit Kumar |
|
| Indian Journal of Endocrinology and Metabolism. 2019; 23(3): 312 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Sitagliptin protects the cognition function of the Alzheimer’s disease mice through activating glucagon-like peptide-1 and BDNF-TrkB signalings |
|
|
| Qing Dong,Shuai-Wen Teng,Yue Wang,Feng Qin,Yue Li,Lu-Lu Ai,Hui Yu |
|
| Neuroscience Letters. 2019; 696: 184 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPKa pathway |
|
|
| Tian Shen,Bilin Xu,Tao Lei,Lin Chen,Cuiping Zhang,Zhenhua Ni |
|
| Experimental and Therapeutic Medicine. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Effect of sitagliptin, a DPP-4 inhibitor, against DENA-induced liver cancer in rats mediated via NF-?B activation and inflammatory cytokines |
|
|
| Weidong Jiang,Dacheng Wen,Zhaohua Cheng,Yongsheng Yang,Ge Zheng,Fangying Yin |
|
| Journal of Biochemical and Molecular Toxicology. 2018; : e22220 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention |
|
|
| Sin Yee Tan,Joyce Ling Mei Wong,Yan Jinn Sim,Su Sie Wong,Safa Abdelgadir Mohamed Elhassan,Sean Hong Tan,Grace Pei Ling Lim,Nicole Wuen Rong Tay,Naveenya Chetty Annan,Subrat Kumar Bhattamisra,Mayuren Candasamy |
|
| Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
The new paradigm for androgenetic alopecia and plant-based folk remedies: 5a-reductase inhibition, reversal of secondary microinflammation and improving insulin resistance |
|
|
| Nicholas John Sadgrove |
|
| Journal of Ethnopharmacology. 2018; 227: 206 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Two Novel Bioactive Peptides from Antarctic Krill with Dual Angiotensin Converting Enzyme and Dipeptidyl Peptidase IV Inhibitory Activities |
|
|
| Wei Ji,Chaohua Zhang,Hongwu Ji |
|
| Journal of Food Science. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
The Antidiabetic Mechanisms of Polyphenols Related to Increased Glucagon-Like Peptide-1 (GLP1) and Insulin Signaling |
|
|
| J. Domínguez Avila,Joaquín Rodrigo García,Gustavo González Aguilar,Laura de la Rosa |
|
| Molecules. 2017; 22(6): 903 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 21 |
Purification, identification and molecular mechanism of two dipeptidyl peptidase IV (DPP-IV) inhibitory peptides from Antarctic krill ( Euphausia superba ) protein hydrolysate |
|
|
| Wei Ji,Chaohua Zhang,Hongwu Ji |
|
| Journal of Chromatography B. 2017; 1064: 56 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 22 |
Incretin-based therapy: renal effects |
|
|
| Anton Ivanovich Korbut,Vadim Valerievich Klimontov |
|
| Diabetes mellitus. 2016; 19(1): 53 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 23 |
Favorable effects of vildagliptin on metabolic and cognitive dysfunctions in streptozotocin-induced diabetic rats |
|
|
| Maha M. El Batsh,Manal M. El Batch,Noha M. Shafik,Ibrahim H. Younos |
|
| European Journal of Pharmacology. 2015; 769: 297 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 24 |
Anti-diabetic potential of Urena lobata leaf extract through inhibition of dipeptidyl peptidase IV activity |
|
|
| Yudi Purnomo,Djoko Wahono Soeatmadji,Sutiman Bambang Sumitro,Mochamad Aris Widodo |
|
| Asian Pacific Journal of Tropical Biomedicine. 2015; 5(8): 645 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 25 |
Bariatric surgery and diabetes remission: how far have we progressed? |
|
|
| Awadhesh Kumar Singh,Sunil Kumar Kota |
|
| Expert Review of Endocrinology & Metabolism. 2015; 10(5): 545 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
